These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The expression of lipopolysaccharide by strains of Shigella dysenteriae, Shigella flexneri and Shigella boydii and their cross-reacting strains of Escherichia coli. Chart H; Daniel RM; Cheasty T FEMS Microbiol Lett; 2009 Mar; 292(1):21-6. PubMed ID: 19222579 [TBL] [Abstract][Full Text] [Related]
6. The Shigella dysenteriae serotype 1 proteome, profiled in the host intestinal environment, reveals major metabolic modifications and increased expression of invasive proteins. Pieper R; Zhang Q; Parmar PP; Huang ST; Clark DJ; Alami H; Donohue-Rolfe A; Fleischmann RD; Peterson SN; Tzipori S Proteomics; 2009 Nov; 9(22):5029-45. PubMed ID: 19813213 [TBL] [Abstract][Full Text] [Related]
7. The iron hand of uropathogenic Escherichia coli: the role of transition metal control in virulence. Robinson AE; Heffernan JR; Henderson JP Future Microbiol; 2018 Jun; 13(7):745-756. PubMed ID: 29870278 [TBL] [Abstract][Full Text] [Related]
8. In vivo versus in vitro protein abundance analysis of Shigella dysenteriae type 1 reveals changes in the expression of proteins involved in virulence, stress and energy metabolism. Kuntumalla S; Zhang Q; Braisted JC; Fleischmann RD; Peterson SN; Donohue-Rolfe A; Tzipori S; Pieper R BMC Microbiol; 2011 Jun; 11():147. PubMed ID: 21702961 [TBL] [Abstract][Full Text] [Related]
9. A case of shigellosis caused by Shigella dysenteriae type 1 and Shigella flexneri type 5B. Bratoeva M; Raitchev G J Hyg Epidemiol Microbiol Immunol; 1991; 35(1):35-9. PubMed ID: 1880406 [TBL] [Abstract][Full Text] [Related]
10. Cooperative Immune Suppression by Escherichia coli and Shigella Effector Proteins. de Jong MF; Alto NM Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29339461 [TBL] [Abstract][Full Text] [Related]
11. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages. Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164 [TBL] [Abstract][Full Text] [Related]
12. Dysentery in patients infected with human immunodeficiency virus in Zimbabwe: an emerging role for Schistosoma mansoni and Escherichia coli O157? Gwavava C; Chihota VN; Gangaidzo IT; Gumbo T Ann Trop Med Parasitol; 2001 Jul; 95(5):509-13. PubMed ID: 11487372 [TBL] [Abstract][Full Text] [Related]
13. Escherichia coli physiology and metabolism dictates adaptation to diverse host microenvironments. Alteri CJ; Mobley HL Curr Opin Microbiol; 2012 Feb; 15(1):3-9. PubMed ID: 22204808 [TBL] [Abstract][Full Text] [Related]
14. Octaplex PCR and fluorescence-based capillary electrophoresis for identification of human diarrheagenic Escherichia coli and Shigella spp. Brandal LT; Lindstedt BA; Aas L; Stavnes TL; Lassen J; Kapperud G J Microbiol Methods; 2007 Feb; 68(2):331-41. PubMed ID: 17079041 [TBL] [Abstract][Full Text] [Related]
15. Pathogenomics of uropathogenic Escherichia coli. Agarwal J; Srivastava S; Singh M Indian J Med Microbiol; 2012; 30(2):141-9. PubMed ID: 22664427 [TBL] [Abstract][Full Text] [Related]